Name: Name:Imazodan
Brand: AABLOCKS
SKU: AA0034XR
Rating: 90 (10 reviews)

Catalog No.: AA0034XR

84243-58-3 | Imazodan

Pack Size： 1g

Purity： 97%

in stock

$41.00 $29.00

Quantity

- +

Add to Card

Order Now

bulk Quotation Request

Technical Information

Catalog Number: AA0034XR

Chemical Name: Imazodan

CAS Number: 84243-58-3

Molecular Formula: C13H12N4O

Molecular Weight: 240.2606

MDL Number: MFCD00867109

SMILES: O=C1CCC(=NN1)c1ccc(cc1)n1cncc1

Properties

Form: Solid

MP: 218℃

Solubility: DMSO: 50 mg/mL, clear, yellow

Storage: Keep in dry area;Room Temperature;

Complexity: 347

Covalently-Bonded Unit Count: 1

Defined Atom Stereocenter Count: 0

Defined Bond Stereocenter Count: 0

Formal Charge: 0

Heavy Atom Count: 18

Hydrogen Bond Acceptor Count: 3

Hydrogen Bond Donor Count: 1

Isotope Atom Count: 0

Rotatable Bond Count: 2

Undefined Atom Stereocenter Count: 0

Undefined Bond Stereocenter Count: 0

XLogP3: 0.7

Upstream Synthesis Route

84243-57-2

84243-58-3

[1]JournalofMedicinalChemistry,1985,vol.28,#10,p.1405-1413

[2]JournalofMedicinalChemistry,1984,vol.27,#9,p.1099-1101

[3]Patent:US4734415,1988,A,

[4]Patent:US4353905,1982,A,

[5]Patent:US4693996,1987,A,

366-77-8

84243-58-3

[1]JournalofMedicinalChemistry,1984,vol.27,#9,p.1099-1101

[2]JournalofMedicinalChemistry,1985,vol.28,#10,p.1405-1413

88427-81-0

84243-58-3

[1]JournalofMedicinalChemistry,1984,vol.27,#9,p.1099-1101

86798-58-5

84243-58-3

[1]JournalofMedicinalChemistry,1984,vol.27,#9,p.1099-1101

Downstream Synthesis Route

84243-58-3

97150-65-7

[1]JournalofMedicinalChemistry,1985,vol.28,p.1405-1413

84243-58-3

84243-59-4

[1]JournalofMedicinalChemistry,1985,vol.28,p.1405-1413

[2]Patent:US4353905,1982,A

84243-57-2

84243-58-3

[1]JournalofMedicinalChemistry,1985,vol.28,p.1405-1413

[2]JournalofMedicinalChemistry,1984,vol.27,p.1099-1101

[3]Patent:US4734415,1988,A

[4]Patent:US4353905,1982,A

[5]Patent:US4693996,1987,A

462-06-6

nitricacidsulfuricacid-watermixture

84243-58-3

[1]JournalofMedicinalChemistry,1984,vol.27,p.1099-1101

88427-81-0

84243-58-3

[1]JournalofMedicinalChemistry,1984,vol.27,p.1099-1101

Literature fold

Title: Defining the binding site of levosimendan and its analogues in a regulatory cardiac troponin C-troponin I complex.

Journal: Biochemistry20080715

Title: Phenotype-based screening of mechanistically annotated compounds in combination with gene expression and pathway analysis identifies candidate drug targets in a human squamous carcinoma cell model.

Journal: Journal of biomolecular screening20060801

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology20060501

Title: Mechanisms of leptin secretion from white adipocytes.

Journal: American journal of physiology. Cell physiology20020701

Title: Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.

Journal: The Journal of biological chemistry20020419

Title: Cardiovascular effects of NSP-804 and NSP-805, novel cardiotonic agents with vasodilator properties.

Journal: Journal of cardiovascular pharmacology19930601

Title: 3,4-Dihydroquinolin-2(1H)-ones as combined inhibitors of thromboxane A2 synthase and cAMP phosphodiesterase.

Journal: Journal of medicinal chemistry19920221

Title: Cardiotonic agents. 9. Synthesis and biological evaluation of a series of (E)-4,5-dihydro-6-[2-[4-(1H-imidazol-1-yl)phenyl]ethenyl]-3 (2H)-pyridazinones: a novel class of compounds with positive inotropic, antithrombotic, and vasodilatory activities for the treatment of congestive heart failure.

Journal: Journal of medicinal chemistry19890201